EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC models

Justin Yu, Jacob Gadwa, Richard B Ross, Michael Knitz, Laurel B Darragh, Khalid N M Abdelazeem, Jessica Beynor, Brooke Neupert, Alexander Nguyen, Diemmy Nguyen, Nicholas Olimpo, Sophia Corbo und 4 weitere

Cancer Immunology, Immunotherapy · 2024

DOI: 10.1007/s00262-024-03664-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2024. Verfasst von Justin Yu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA. Hauptthemen laut MEDLINE: Interleukin-7, Head and Neck Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDCD NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinically approved head and neck squamous cell carcinoma (HNSCC) immunotherapies manipulate the immune checkpoint blockade (ICB) axis but have had limited success outside of recurrent/metastatic disease. Interleukin-7 (IL7) has been shown to be essential for effector T-cell survival, activation, and proliferation. Here, we show that IL7 in combination with radiotherapy (RT) is effective in activating CD8 + T-cells for reducing tumor growth. Our studies were conducted using both human papillomavirus related and unrelated orthotopic HNSCC murine models. Immune populations from the tumor, draining lymph nodes, and blood were compared between treatment groups and controls using flow cytometry, proteomics, immunofluorescence staining, and RNA sequencing. Treatment with RT and IL7 (RT + IL7) resulted in significant tumor growth reduction, high CD8 T-cell tumor infiltration, and increased proliferation of T-cell progenitors in the bone marrow. IL7 also expanded a memory-like subpopulation of CD8 T-cells. These results indicate that IL7 in combination with RT can serve as an effective immunotherapy strategy outside of the conventional ICB axis to drive the antitumor activity of CD8 T-cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-7Head and Neck NeoplasmsHumansMiceAnimalsSquamous Cell Carcinoma of Head and NeckMemory T CellsCD8-Positive T-LymphocytesTumor Microenvironment

Stichwörter der Autor:innen

Cancer immunologyImmunotherapyInterleukin-7Memory T cellsRadioimmunotherapy

Substanzen

Interleukin-7

Autor:innen und Institutionen

  • Department of Otolaryngology - Head and Neck Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
  • Department of Radiation Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
  • Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
  • Radiation Biology Research Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.
  • Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
  • Department of Radiation Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA. sana.karam@cuanschutz.edu.

Förderung

  • NCI NIH HHS
  • NIDCD NIH HHS
  • NIH HHS
  • National Institutes of Health
  • NIDCR/NCI

Zitieren

APA

Yu, J., Gadwa, J., Ross, R. B., Knitz, M., Darragh, L. B., Abdelazeem, K. N. M., Beynor, J., Neupert, B., Nguyen, A., Nguyen, D., Olimpo, N., Corbo, S., Van Court, B., D'Alessandro, A., Saviola, A., & Karam, S. D. (2024). IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC models. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03664-y

Vancouver

Yu J, Gadwa J, Ross RB, Knitz M, Darragh LB, Abdelazeem KNM, et al. IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC models. Cancer Immunology, Immunotherapy. 2024. doi:10.1007/s00262-024-03664-y

BibTeX
@article{Yu2024,
  author = {Yu, Justin and Gadwa, Jacob and Ross, Richard B and Knitz, Michael and Darragh, Laurel B and Abdelazeem, Khalid N M and Beynor, Jessica and Neupert, Brooke and Nguyen, Alexander and Nguyen, Diemmy and Olimpo, Nicholas and Corbo, Sophia and Van Court, Benjamin and D'Alessandro, Angelo and Saviola, Anthony and Karam, Sana D},
  title = {IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC models},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2024},
  doi = {10.1007/s00262-024-03664-y}
}
Kostenlos starten →